Afleveringen
-
David Eichenbaum, MD, will discuss the bioresorbable, hydrogel axitinib intravitreal implant that is under investigation in the SOL-1 phase 3 trial for the treatment of neovascular age-related macular degeneration.
This activity is supported by an independent medical education grant from Ocular Therapeutix.
Click here to view the webinar event, which includes images from the talk.
Want to register with Evolve Medical Education? Click here. -
Margaret A. Chang, MD, MS, will discuss gene therapies in the pipeline for the treatment of neovascular age-related macular degeneration.
This activity is supported by an independent medical education grant from Ocular Therapeutix.
Click here to view the webinar event, which includes images from the talk.
Want to register with Evolve Medical Education? Click here. -
Zijn er afleveringen die ontbreken?
-
Drs. Dilsher Dhoot and Arshad M. Khanani explain the key aspects of the recently released FDA guidelines for clinical trial design in neovascular age-related macular degeneration and how these changes will influence the interpretation of clinical trial data and the subsequent integration of these therapies into clinical practice.
This activity is supported by an independent medical education grant from Ocular Therapeutix.
Click here to view the webinar event, which includes images from the talk.
Want to register with Evolve Medical Education? Click here. -
Drs. Donaldson and Starr delve into cenegermin’s clinical trial data and whether or not it should be used in patients with stage 1 neurotrophic keratitis (NK). They also discuss a handful of investigational agents for treating NK.
This activity is supported by an unrestricted educational grant from Dompé.
Click here to view the webinar event, which includes images from the talk.
Check out the central hub of this webinar series.
Want to register with Evolve Medical Education? Click here. -
Kendall E. Donaldson, MD, MS and Christopher E. Starr, MD, highlight best practices when treating neurotrophic keratitis, including differential diagnosis, corneal sensitivity testing, the new classification system, treatments options for each stage, and pipeline therapies.
This activity is supported by an unrestricted educational grant from Dompé.
Click here to view the webinar event, which includes images from the talk.
Check out the central hub of this webinar series.
Want to register with Evolve Medical Education? Click here. -
Kendall E. Donaldson, MD, MS and Christopher E. Starr, MD, discuss why it’s important to treat stage 1 neurotrophic keratitis, the treatment options for each stage, and a patient who was treated with multiple therapies.
This activity is supported by an unrestricted educational grant from Dompé.
Click here to view the webinar event, which includes images from the talk.
Check out the central hub of this webinar series.
Want to register with Evolve Medical Education? Click here. -
In this case-based discussion focused on diabetic macular edema, Murtaza Adam, MD, FASRS, and Lejla Vajzovic, MD, FASRS, highlight the use of more durable treatment options and how to incorporate these second-generation therapies into the armamentarium.
This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.
Click here to view the webinar event, which includes images from the talk.
Check out the central hub of this webinar series.
Want to register with Evolve Medical Education? Click here. -
Murtaza Adam, MD, FASRS, and Lejla Vajzovic, MD, FASRS, discuss two cases involving patients with neovascular age-related macular degeneration and the decision-making process used to determine the best treatment approaches.
This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.
Click here to view the webinar event, which includes images from the talk.
Check out the central hub of this webinar series.
Want to register with Evolve Medical Education? Click here. -
Back by popular demand, this fun and exciting game show-style program features key opinion leaders (KOLs) as contestants!
Hosted by Dr. Blake K. Williamson, this episode is full of learning and laughter! The winner of Round 2, Dr. Sumitra Khandelwal, joins two new KOLs, Drs. Kendall E. Donaldson & Vance Thompson, to battle it out in this final round!
Who is the champion? Listen now to find out!
This activity is supported by an independent educational grant from Alcon.
Click here to view the webinar event, which includes images from the talk.
Check out the central hub of this webinar series.
Want to register with Evolve Medical Education? Click here. -
This popular program is a fun and exciting game show-style quiz competition that features key opinion leaders (KOLs) as contestants. Hosted by Program Chair Blake K. Williamson, MD, MPH, MS, the second of three rounds features Sumitra Khandelwal, MD; R. Luke Rebenitsch, MD; and Bennett Walton, MD, MBA, as contestants.
Dr. Williamson presents complex cataract surgery case studies and each KOL weighs in on their preferred treatment option. Find out who will advance to the final round!
This activity is supported by an independent educational grant from Alcon.
Click here to view the webinar event, which includes images from the talk.
Check out the central hub of this webinar series.
Want to register with Evolve Medical Education? Click here. -
This popular program is a fun and exciting game show-style quiz competition that features key opinion leaders (KOLs) as contestants. Hosted by Program Chair Blake K. Williamson, MD, MPH, MS, the first of three rounds features Zaina Al-Mohtaseb, MD; Michael Greenwood, MD; and Bennett Walton, MD, MBA, as contestants.
Dr. Williamson presents complex cataract surgery case studies and each KOL weighs in on their preferred treatment option. Find out who will advance to the next round!
This activity is supported by an independent educational grant from Alcon.
Click here to view the webinar event, which includes images from the talk.
Check out the central hub of this webinar series.
Want to register with Evolve Medical Education? Click here. -
In this insightful microlearning podcast, Dr. Kim Cockerham explores the impact of TED on patients' quality of life, outlines essential questions for diagnosis, and describes a compelling case of inflammatory TED that recurred following orbital decompression surgery and presented with diplopia.
This activity is supported by an unrestricted educational grant from Horizon Therapeutics.
Click here to view the webinar event, which includes images from the talk.
Check out the central hub of this webinar series.
Want to register with Evolve Medical Education? Click here. -
Join Amina Malik, MD, as she describes the common signs and symptoms of TED and offers valuable insights into successfully treating and comanaging a case of moderate-to-severe TED.
This activity is supported by an unrestricted educational grant from Horizon Therapeutics.
Click here to view the webinar event, which includes images from the talk.
Check out the central hub of this webinar series.
Want to register with Evolve Medical Education? Click here. -
In this informative episode, Dr. Amina Malik navigates the different classification systems for TED severity and inflammatory activity, explores the treatment options for varying severity of disease, and concludes with a case study highlighting the successful use of biologic therapy in managing chronic TED.
This activity is supported by an unrestricted educational grant from Horizon Therapeutics.
Click here to view the webinar event, which includes images from the talk.
Check out the central hub of this webinar series.
Want to register with Evolve Medical Education? Click here. -
Kim Cockerham, MD, FACS, explains the challenges of diagnosing TED and recounts a case of advanced TED, which involved a patient who had previously been misdiagnosed with dry eye and ocular hypertension/glaucoma by six other eye care providers, and was eventually successfully treated with teprotumumab.
This activity is supported by an unrestricted educational grant from Horizon Therapeutics.
Click here to view the webinar event, which includes images from the talk.
Check out the central hub of this webinar series.
Want to register with Evolve Medical Education? Click here. -
In this episode, Carl J. Danzig, MD and John W. Kitchens, MD, discuss two case studies, one involving a 15-year-old who presents with neovascularization and an elderly patient with an extensive history of treatment who was switched to a second-generation therapy.
This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.
Click here to view the webinar event, which includes images from the talk.
Check out the central hub of this webinar series.
Want to register with Evolve Medical Education? Click here. -
Carl J. Danzig, MD and John W. Kitchens, MD, discuss two case studies, including a treatment-naïve patient with proliferative diabetic retinopathy and diabetic macular edema and a patient with a long history of anti-VEGF injections who was switched to aflibercept 8 mg.
This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.
Click here to view the webinar event, which includes images from the talk.
Check out the central hub of this webinar series.
Want to register with Evolve Medical Education? Click here. -
David Chin Yee, MD, FASRS and Esther Lee Kim, MD, discuss second-generation retinal disease therapies and how they may offer benefits for certain patients. These retina specialists also share their experience with the newer agents through challenging real-world case studies.
This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.
Click here to view the webinar event, which includes images from the talk.
Check out the central hub of this webinar series.
Want to register with Evolve Medical Education? Click here. -
David Chin Yee, MD, FASRS and Esther Lee Kim, MD, discuss clinical trial data of newer, longer duration retinal disease therapies and share real-world case studies utilizing these new agents for their patients.
This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.
Click here to view the webinar event, which includes images from the talk.
Check out the central hub of this webinar series.
Want to register with Evolve Medical Education? Click here. -
Classification of neurotrophic keratitis is moving away from the Mackie system. Drs. Nichols and Whitley highlight the Neurotrophic Keratitis Study Group classification system and explain the clinical features of each stage.
This activity is supported by an unrestricted educational grant from Dompé.
Click here to view the webinar event, which includes images from the talk.
Check out the central hub of this webinar series.
Want to register with Evolve Medical Education? Click here. - Laat meer zien
